SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-055102
Filing Date
2023-05-02
Accepted
2023-05-02 17:27:22
Documents
14
Period of Report
2023-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314358d1_8k.htm   iXBRL 8-K 26942
2 EXHIBIT 99.1 tm2314358d1_ex99-1.htm EX-99.1 99642
6 GRAPHIC tm2314358d1_ex99-1img01.jpg GRAPHIC 12589
  Complete submission text file 0001104659-23-055102.txt   334469

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctso-20230502.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctso-20230502_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctso-20230502_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2314358d1_8k_htm.xml XML 3483
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

IRS No.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 23880591
SIC: 3841 Surgical & Medical Instruments & Apparatus